(R) - (+) -Trityl glycidyl ether

(R) - (+) -Trityl glycidyl ether, a heterocyclic compound, is a precursor that can be used to synthesize glycerophospholipids, as well as compounds with antiviral and antimalarial activities[1][2].

Product Specifications

CAS Number

[65291-30-7]

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Drug Intermediate

Type

Reference compound

Related Pathways

Others

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/r-plus-trityl-glycidyl-ether.html

Purity

97.0

Smiles

[C@@H]1(CO1)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4

Molecular Formula

C22H20O2

Molecular Weight

316.39

Precautions

H302, H315, H319, H335

References & Citations

[1]Baszczyňski O, et al. Synthesis and antiviral activity of N9-[3-fluoro-2- (phosphonomethoxy) propyl] analogues derived from N6-substituted adenines and 2,6-diaminopurines. Bioorg Med Chem. 2011 Apr 1;19 (7) :2114-24. |[2]Sato E, et al. Design, synthesis and anti-malarial activities of synthetic analogs of biselyngbyolide B, a Ca2+ pump inhibitor from marine cyanobacteria. Bioorg Med Chem Lett. 2018 Feb 1;28 (3) :298-301.